HIPRAPOX
HIPRAPOX
Authorised
- Fowlpox virus, strain FPV-92, Live
Product identification
Medicine name:
HIPRAPOX
HIPRAPOX
Active substance:
- Fowlpox virus, strain FPV-92, Live
Target species:
-
Turkey
-
Chicken
Route of administration:
-
Skin scarification
-
Wing-web-stab use
Product details
Active substance and strength:
-
Fowlpox virus, strain FPV-92, Live2511890.00/50% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
-
Skin scarification
-
Turkey
-
Meat and offal0day
-
-
-
Wing-web-stab use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD12
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- box containing 5 vials (1000 doses) lyophilisate and 5 vials of 10 ml of solvent
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- PEI.V.11803.01.1
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0258/001
Concerned member states:
-
Germany
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 6/04/2023
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 11/02/2025
eu-PUAR-hiprapox-en.pdf
English (PDF)
Download Published on: 6/04/2023
How useful was this page?:
